| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |